HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves.

AuthorsAnthony P Carnicelli, Raffaele De Caterina, Jonathan L Halperin, Giulia Renda, Christian T Ruff, Marco Trevisan, Francesco Nordio, Michele F Mercuri, Elliott Antman, Robert P Giugliano, ENGAGE AF-TIMI 48 Investigators
JournalCirculation (Circulation) Vol. 135 Issue 13 Pg. 1273-1275 (03 28 2017) ISSN: 1524-4539 [Electronic] United States
PMID28209729 (Publication Type: Letter, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticoagulants
  • Factor Xa Inhibitors
  • Pyridines
  • Thiazoles
  • Warfarin
  • edoxaban
Topics
  • Anticoagulants (administration & dosage, adverse effects)
  • Atrial Fibrillation (blood, complications, diagnosis, drug therapy)
  • Bioprosthesis (adverse effects)
  • Blood Coagulation (drug effects)
  • Factor Xa Inhibitors (administration & dosage, adverse effects)
  • Heart Valve Prosthesis (adverse effects)
  • Heart Valve Prosthesis Implantation (adverse effects, instrumentation)
  • Hemorrhage (chemically induced)
  • Humans
  • Pyridines (administration & dosage, adverse effects)
  • Risk Factors
  • Stroke (blood, diagnosis, etiology, prevention & control)
  • Thiazoles (administration & dosage, adverse effects)
  • Thromboembolism (blood, diagnosis, etiology, prevention & control)
  • Treatment Outcome
  • Warfarin (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: